Catalyst Pharmaceuticals Inc Earnings

Catalyst Pharmaceuticals Inc’s revenue jumped 15.31% since last year same period to $148.39Mn in the Q3 2025. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 1.25% jump in its revenue since last 3-months.

Catalyst Pharmaceuticals Inc’s net profit jumped 20.28% since last year same period to $52.78Mn in the Q3 2025. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 1.3% jump in its net profits since last 3-months.

Catalyst Pharmaceuticals Inc’s net profit margin jumped 4.31% since last year same period to 35.57% in the Q3 2025. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 0.05% jump in its net profit margins since last 3-months.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.36 - a -7.69% fall from last quarter’s estimates.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.36.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Catalyst Pharmaceuticals Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.